OpenReview.net
  • Login

Ivan Tarapov

Researcher, Microsoft
Joined
November 2023

Names

Ivan Tarapov (Preferred)

Emails

****@tarapov.com (Confirmed)
, 
****@microsoft.com (Confirmed)

Personal Links

LinkedIn

Career & Education History

Researcher
Microsoft (microsoft.com)
2016 – Present

Advisors, Relations & Conflicts

Coauthor
Alberto Santamaria-Pang
2020 – Present

Expertise

medical imaging
, 
healthcare AI
, 
generative AI
, 
drift detection
, 
computer vision
2017 – Present

Publications

  • BiomedParse-V : Scaling Foundation Model for Universal Text-guided Volumetric Biomedical Image Segmentation

    Theodore Zhao, Ho Hin Lee, Alberto Santamaria-Pang, Noel C Codella, Sid Kiblawi, Yu Gu, Yu Fang, Wenxuan Teng, Naiteek Sangani, Ivan Tarapov, Matthew P. Lungren, Matthias Blondeel, Tristan Naumann, Naoto Usuyama, Sheng Wang, Paul Vozila, Hoifung Poon, Mu Wei
    • CVPR 2025 Workshop MedSegFM Submission
    • Readers: Everyone
  • WaveFormer: Leveraging Wavelet Transformation for Multi-Scale Token Interactions in Hierarchical Transformers

    MD Mahfuz Al Hasan, Mahdi Zaman, Alberto Santamaria-Pang, Abdul Jawad, Ho Hin Lee, Antika Roy, Yaser Fallah, Ivan Tarapov, Navid Asadi, Reza Forghani
    • ICLR 2025 Conference Withdrawn Submission
    • Readers: Everyone

Co-Authors

  • Abdul Jawad
  • Alberto Santamaria-Pang
  • Antika Roy
  • Ho Hin Lee
  • Hoifung Poon
  • MD Mahfuz Al Hasan
  • Mahdi Zaman
  • Matthew P. Lungren
  • Matthias Blondeel
  • Mu Wei
  • Naiteek Sangani
  • Naoto Usuyama
  • Navid Asadi
  • Noel C Codella
  • Paul Vozila
  • Reza Forghani
  • Sheng Wang
  • Sid Kiblawi
  • Theodore Zhao
  • Tristan Naumann
  • Wenxuan Teng
  • Yaser Fallah
  • Yu Fang
  • Yu Gu
  • About OpenReview
  • Hosting a Venue
  • All Venues
  • Contact
  • Sponsors
  • Donate
  • FAQ
  • Terms of Use / Privacy Policy
  • News
  • About OpenReview
  • Hosting a Venue
  • All Venues
  • Sponsors
  • News
  • FAQ
  • Contact
  • Donate
  • Terms of Use
  • Privacy Policy

OpenReview is a long-term project to advance science through improved peer review with legal nonprofit status. We gratefully acknowledge the support of the OpenReview Sponsors. © 2026 OpenReview